Extrahierung von Histogramm- und Textureigenschaften aus parametrischen F-18-FET PET Bildern zur molekulargenetischen und histologischen Klassifizierung von Gliomen. (German)

Autor: Kaiser, L, Grosch, M, Ahmadi, SA, Unterrainer, M, Holzgreve, A, Vettermann, FJ, Mille, E, Brosch, J, Gosewisch, A, Suchorska, B, Navab, N, Kreth, FW, Tonn, JC, Böning, G, Bartenstein, P, Albert, NL, Ziegler, S

Publikováno v: NuclearMedicine / Nuklearmedizin; 2020, Vol. 59 Issue 2, p91-91, 1p

Voxel-weise Korrelation von Aminosäure- und TSPO-PET mit relativer Kontrastmittelanreicherung im T1-gewichteten MRT bei Gliomen

Autor: Kaiser, L, Holzgreve, A, Vettermann, FJ, Brosch-Lenz, J, Gosewisch, A, Böning, G, Rupprecht, R, Tonn, JC, Bartenstein, P, Ziegler, S, Albert, NL

Publikováno v: Nuklearmedizin. Nuclear medicine; April 2021, Vol. 60 Issue: 2

⁶⁸ Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results.

Autor: Mittlmeier LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Lena.Mittlmeier@med.uni-muenchen.de.; Department of Urology, University Hospital, LMU Munich, Munich, Germany. Lena.Mittlmeier@med.uni-muenchen.de., Todica A; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Gildehaus FJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Unterrainer M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Beyer L; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Brendel M; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Albert NL; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Ledderose ST; Institute of Pathology, LMU Munich, Munich, Germany., Vettermann FJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Schott M; Department of Urology, University Hospital, LMU Munich, Munich, Germany., Rodler S; Department of Urology, University Hospital, LMU Munich, Munich, Germany., Marcon J; Department of Urology, University Hospital, LMU Munich, Munich, Germany., Ilhan H; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Cyran CC; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Stief CG; Department of Urology, University Hospital, LMU Munich, Munich, Germany., Staehler M; Department of Urology, University Hospital, LMU Munich, Munich, Germany., Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Apr; Vol. 49 (5), pp. 1711-1720. Date of Electronic Publication: 2021 Oct 28.

Impact of TSPO Receptor Polymorphism on [ ¹⁸ F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders.

Autor: Vettermann FJ; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Harris S; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Schmitt J; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Unterrainer M; Department of Radiology, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Lindner S; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Rauchmann BS; Department of Radiology, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.; Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Palleis C; Department of Neurology, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Weidinger E; Department of Neurology, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Beyer L; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Eckenweber F; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Schuster S; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Biechele G; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Ferschmann C; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Milenkovic VM; Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany., Wetzel CH; Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany., Rupprecht R; Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany., Janowitz D; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Buerger K; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, 81377 Munich, Germany., Perneczky R; Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College, London SW7 2AZ, UK.; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany., Höglinger GU; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.; Department of Neurology, Hannover Medical School, 30625 Hannover, Germany., Levin J; Department of Neurology, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany., Haass C; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.; Chair of Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, 82152 Planegg, Germany., Tonn JC; Department of Neurosurgery, University Hospital of Munich, 81377 Munich, Germany., Niyazi M; Department of Radiation Oncology, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany., Bartenstein P; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany., Albert NL; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany., Brendel M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany.

Publikováno v: Life (Basel, Switzerland) [Life (Basel)] 2021 May 26; Vol. 11 (6). Date of Electronic Publication: 2021 May 26.

Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET.

Autor: Vettermann FJ, Unterrainer M, Ruf V; Neuropathology., Fleischmann DF; Radiation Oncology, University Hospital, LMU Munich, Munich., Rupprecht R; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg., Forbrig R; Institute of Neuroradiology., Herms J; Neuropathology., Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL

Publikováno v: Clinical nuclear medicine [Clin Nucl Med] 2020 Dec; Vol. 45 (12), pp. 992-993.